Current Cancer Reports
Current Cancer Reports (CCR) (ISSN: 2661-3166) is an open access, continuously published, international, refereed journal dedicated to publish articles covering all areas of carcinogenesis, prevention, diagnosis, treatment, drug development and related policy.
The journal aims at promoting research communications, and providing a platform for doctors, researchers, physicians, pharmacists and healthcare professionals to find the most recent advances in all areas of cancer-related fields. Current Cancer Reports accepts original research articles, reviews, minireviews, case reports, image data, novel hypothesis and rapid communication covering all respects of carcinogenesis and cancer therapy.
The columns of the journal include, but not limited to:
• Original articles and new techniques in cancer research and therapy
• Quick reports
• Case reports
• Clinicopathologic discussion
• Discussion of clinical case
• Expert views
• Exchange of experience
• Novel hypothesis
• Correspondence
• Publish the original incoming letter
• Academic contending/Debate
• etc.
2022-04-21
Current Cancer Reports is indexed in PubMed, CAS, Scilit, BASE, J-Gate, EuroPub, Dimensions, Crossref, Google Scholar, Baidu Scholar, NLB of Singapore, etc., and being indexed in other authoritative academic databases is under application.
The mock Impact Factor of Current Cancer Reports is 1.20.
Vol 5 (2023)
Published: 2023-04-13
Pages 156-159
Page 153-155
| ISSN: 2661-3166 Abbreviation: Curr Cancer Rep Editor-in-Chief: Prof. Yingyu Cui Publishing Frequency: Continuous publication Article Processing Charges (APC): Click here for more details Publishing Model: Open Access |
ISSN 2661-3166
Ping Wang
